Form 4: Accelerate Diagnostics Director Hany Massarany Reports Acquisition of Restricted Stock Units

Director Hany Massarany reports acquisition of 66,667 Restricted Stock Units (RSUs) in Accelerate Diagnostics, Inc.

Summary

• On May 20, 2024, Hany Massarany, a director of Accelerate Diagnostics, Inc., was granted 66,667 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
• The RSUs vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served.
• Following the transaction, Massarany beneficially owns 66,667 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing regarding stock grants, which is neutral in sentiment.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.

Future Outlook

The RSUs will vest on the first anniversary of the grant date, contingent on continued service.

Industry Context

Grants of stock options and restricted stock units are a common way to compensate directors and align their interests with shareholders.

Stakeholder Impact

• The grant of RSUs aligns the director's interests with those of the shareholders.

Key Dates